Tirzepatide 99.9% Purity — Xingruida XdrCertificate of Analysis · Independent third-party lab result
LabE tested this Tirzepatide batch (Blue Cap) at 99.9% purity via HPLC. However, the tested quantity was significantly lower than the label (17.7mg vs 30mg, a -41% deviation). No endotoxin test results were available. The test is recent (under 3 months), and customers can cross-check on the lab's public verification URL.
- significant quantity deviation
- no endotoxin test
- Test date
- 2026-03-02
- Testing lab
- LabE
- Batch / lot
- [NAME_REDACTED]
- Quantity
- 17.7mg
- Endotoxins
- —
- Assay method
- HPLC + mass quantification + endotoxins
- Test score
- 6.7
- Label dose
- 30mg
How this result compares
This Tirzepatide certificate's tested purity of 99.90% ranks higher than 73% of the 7378 Tirzepatide certificates with a purity result we have catalogued (median 99.82%).
Tested 2026-03-02 by LabE via HPLC + mass quantification + endotoxins. This test is newer than 68% of our catalogued Tirzepatide certificates.
Xingruida Xdr has 73 certificates in our corpus, including 21 for Tirzepatide at a median tested purity of 99.80%.
Test report image
Finnrick
Artifact capturedWe have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact shown here.
Verify on the upstream labSaved source document
sha256:c8233bb1d1c24172…
— immutable copy held by TitrateLab